Baidu
map

Oncotarget:α亚麻酸可抑制缺氧微环境具有抗癌作用

2017-10-21 MedSci MedSci原创

α-亚麻酸是必需的多不饱和脂肪酸,据研究报道具有抗癌潜力,但是并没有明确的假设或机制。本研究旨在验证α亚麻酸体外和体内对线粒体凋亡、缺氧微环境和脂肪酸合成的影响。对于ER + MCF-7细胞,α亚麻酸的IC 50值为17.55μM。吖啶橙/溴化乙锭和JC-1染色研究发现,α-亚麻酸处理后,早期和晚期凋亡信号以及线粒体去极化明显存在。α-亚麻酸使得细胞周期停滞在G2/M期。随后,研究人员探究了体内α

α-亚麻酸是必需的多不饱和脂肪酸,据研究报道具有抗癌潜力,但是并没有明确的假设或机制。本研究旨在验证α亚麻酸体外和体内对线粒体凋亡、缺氧微环境和脂肪酸合成的影响。

对于ER + MCF-7细胞,α亚麻酸的IC 50值为17.55μM。吖啶橙/溴化乙锭和JC-1染色研究发现,α-亚麻酸处理后,早期和晚期凋亡信号以及线粒体去极化明显存在。α-亚麻酸使得细胞周期停滞在G2/M期。随后,研究人员探究了体内α亚麻酸对抗7, 12二甲基苯并蒽诱发癌变的效果。

组织病理学结构恢复和肿瘤微血管丧失等可说明α亚麻酸处理可明显影响细胞增殖。1 H NMR研究显示,α-亚麻酸可恢复正常的代谢。免疫印迹和qRT-PCR研究显示,α亚麻酸处理后,参与线粒体介导的死亡凋亡途径和缺氧微环境的抑制。

综上所述,该研究结果表明,α亚麻酸介导线粒体凋亡,抑制缺氧微环境,抑制脂肪酸的合成,具有抗癌作用。

原始出处:

Subhadeep Roy, Atul Kumar Rawat, et al., Alpha-linolenic acid stabilizes HIF-1 α and downregulates FASN to promote mitochondrial apoptosis for mammary gland chemoprevention. Oncotarget. 2017 Sep 19; 8(41): 70049–70071. Published online 2017 Jul 25. doi: 10.18632/oncotarget.19551

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1795477, encodeId=b0171e954773a, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 12 05:26:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255061, encodeId=2cb325506160, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Sun Oct 22 09:48:36 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254952, encodeId=aa7625495270, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Oct 21 23:32:40 CST 2017, time=2017-10-21, status=1, ipAttribution=)]
    2018-08-12 仁医06
  2. [GetPortalCommentsPageByObjectIdResponse(id=1795477, encodeId=b0171e954773a, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 12 05:26:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255061, encodeId=2cb325506160, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Sun Oct 22 09:48:36 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254952, encodeId=aa7625495270, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Oct 21 23:32:40 CST 2017, time=2017-10-21, status=1, ipAttribution=)]
    2017-10-22 186****0580(小山羊)

    学习了谢谢了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1795477, encodeId=b0171e954773a, content=<a href='/topic/show?id=248e1e1345b' target=_blank style='color:#2F92EE;'>#target#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17134, encryptionId=248e1e1345b, topicName=target)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Sun Aug 12 05:26:00 CST 2018, time=2018-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255061, encodeId=2cb325506160, content=学习了谢谢了, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLPeNmuNF9ibgMfMOAs7Iic5MpiaU8RLmRH67xCKuk5wzfhb7G4ib7ia6z9lrnsTicj1nAUfEOMecZDtvvu/0, createdBy=d7f91939785, createdName=186****0580(小山羊), createdTime=Sun Oct 22 09:48:36 CST 2017, time=2017-10-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=254952, encodeId=aa7625495270, content=不错的文章值得推荐, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04f22055142, createdName=131****2916, createdTime=Sat Oct 21 23:32:40 CST 2017, time=2017-10-21, status=1, ipAttribution=)]
    2017-10-21 131****2916

    不错的文章值得推荐

    0

Baidu
map
Baidu
map
Baidu
map